ncing.' If we enter into the New Financing Facilities, we may use the proceeds thereof to repay all amounts outstanding under, and to terminate, the ABS/Safeway ABL Agreement, the NAI ABL Agreement and the Letter of Credit Facility Agreement (each as defined herein and collectively, the "Specified Existing Facilities") 1

vanced against the ABS/Safeway ABL Priority Collateral subject to the sale, casualty or other disposition). Interest. Amounts outstanding under the ABS/Safeway ABL Agreement bear interest at a rate per annum equal to, at our option (a) the base rate, plus an applicable margin equal to (i) 0.50% (if daily average excess a

e, inventory and prescription files for inclusion in the borrowing base is determined in accordance with certain customary criteria specified in the ABS/Safeway ABL Agreement, including periodic appraisals. The terms of the ABS/Safeway ABL Agreement provide that appraisals of assets included in the borrowing base are to b